Total Payments
$1,330
2024 Payments
$249.88
Companies
25
Transactions
48
Medicare Patients
579
Medicare Billing
$96,635
Payment Breakdown by Category
Food & Beverage$1,144 (86.0%)
Education$185.90 (14.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,144 | 46 | 86.0% |
| Education | $185.90 | 2 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $159.26 | 4 | $0 (2023) |
| Amgen Inc. | $149.89 | 3 | $0 (2023) |
| Adaptive Biotechnologies Corporation | $140.82 | 5 | $0 (2024) |
| Epizyme, Inc., | $124.49 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $106.01 | 2 | $0 (2023) |
| Lilly USA, LLC | $88.73 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $65.42 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $64.75 | 3 | $0 (2024) |
| SOBI, INC | $46.84 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $39.37 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.88 | 11 | Adaptive Biotechnologies Corporation ($62.84) |
| 2023 | $584.35 | 21 | Amgen Inc. ($135.86) |
| 2022 | $471.49 | 15 | Epizyme, Inc., ($124.49) |
| 2021 | $23.83 | 1 | Sunovion Pharmaceuticals Inc. ($23.83) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: HEMATOLOGY | ||||||
| 06/13/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Oncology | ||||||
| 06/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/26/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $47.42 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
| 10/10/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 08/18/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.06 | General |
| 07/03/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Oncology | ||||||
| 06/20/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $13.59 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Oncology | ||||||
| 06/14/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/06/2023 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 05/18/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: Oncology | ||||||
| 05/15/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Hematology/Oncology | ||||||
| 05/02/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Oncology | ||||||
| 03/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 553 | 1,094 | $320,012 | $94,363 |
| 2022 | 1 | 26 | 27 | $7,236 | $2,272 |
Total Patients
579
Total Services
1,121
Medicare Billing
$96,635
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 656 | $175,808 | $51,349 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 137 | 264 | $95,304 | $30,261 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $25,420 | $5,801 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 85 | $15,385 | $4,839 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $6,695 | $1,818 | 27.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 12 | 14 | $1,400 | $294.98 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 27 | $7,236 | $2,272 | 31.4% |
About Lindsey Polcari
Lindsey Polcari is a Family healthcare provider based in Sierra Vista, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2021. The National Provider Identifier (NPI) number assigned to this provider is 1710659230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsey Polcari has received a total of $1,330 in payments from pharmaceutical and medical device companies, with $249.88 received in 2024. These payments were reported across 48 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,144).
As a Medicare-enrolled provider, Polcari has provided services to 579 Medicare beneficiaries, totaling 1,121 services with total Medicare billing of $96,635. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Sierra Vista, AZ
- Active Since 10/03/2021
- Last Updated 05/15/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710659230
Products in Payments
- clonoSEQ (Device) $140.82
- EVENITY (Biological) $124.99
- TAZVERIK (Drug) $124.49
- VERZENIO (Drug) $88.73
- LYNPARZA (Drug) $85.95
- KEYTRUDA (Biological) $65.42
- JAKAFI (Drug) $45.72
- LUTATHERA (Drug) $44.47
- PROVENGE (Drug) $31.28
- Jivi (Drug) $31.14
- OJJAARA (Drug) $30.50
- Onivyde (Drug) $26.73
- DOPTELET (Drug) $26.16
- NINLARO (Drug) $25.55
- Orserdu (Drug) $24.08
- LONHALA MAGNAIR (Drug) $23.83
- JEVTANA (Drug) $22.33
- OPDIVO (Biological) $21.17
- Doptelet (Drug) $20.68
- KISQALI (Drug) $20.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sierra Vista
Kyle White, Fnp-C, FNP-C
Family — Payments: $13,579
Family $13,579
Maureen Bay, Cnp, CNP
Family — Payments: $5,996
Family $5,996
Dustin Smith, Fnp-C, FNP-C
Family — Payments: $3,907
Family $3,907
Andrea Ruble, Rn, Fnp-Bc, RN, FNP-BC
Family — Payments: $1,809
Family $1,809
Christine Grassman, Np, NP
Family — Payments: $1,529
Family $1,529
Micheal Kaiser, Aprn-Rnp, APRN-RNP
Family — Payments: $1,208
Family $1,208